IceCure Medical Ltd (ICCM)

IceCure Medical Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for IceCure Medical stock has a target of 2.50, which predicts a 264.22% increase from the current stock price of 0.69.

Price Target: $2.50 (+264.22%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$2.50	$2.50	$2.50	$2.50
Change	+264.22%	+264.22%	+264.22%	+264.22%

* Price targets were last updated on Oct 7, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for IceCure Medical is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $2 → $2.5	Strong Buy	Maintains	$2 → $2.5	+264.22%	Oct 7, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $2.5 → $2	Strong Buy	Maintains	$2.5 → $2	+191.38%	Aug 15, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $2.5	Strong Buy	Reiterates	$2.5	+264.22%	May 29, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $2.5	Strong Buy	Reiterates	$2.5	+264.22%	Mar 28, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $2.5	Strong Buy	Reiterates	$2.5	+264.22%	Nov 27, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

3.74M

Increased by 13.67%

from 3.29M

Revenue Next Year

5.18M

Increased by 38.55%

from 3.74M

EPS This Year

-0.22

from -0.30

EPS Next Year

-0.15

from -0.22

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	3.87M	4.14M	3.09M	3.23M	3.29M	3.74M	5.18M
Revenue Growth	132.76%	6.98%	-25.45%	4.67%	1.92%	13.67%	38.55%
EPS	-0.22	-0.35	-0.46	-0.32	-0.30	-0.22	-0.15
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	4.6M	5.3M
Avg	3.7M	5.2M
Low	2.9M	5.0M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	38.3%	42.6%
Avg	13.7%	38.5%
Low	-10.6%	33.1%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-0.21	-0.06
Avg	-0.22	-0.15
Low	-0.23	-0.23

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.